AbbVie: Canaccord Genuity raises target price to $338 from $290
ABBV•Canaccord Genuity raised its target price for AbbVie to $338 from $290.
Related News
Moocoo Ventures sees AI credit squeeze favoring hyperscalers over neoclouds
CRWV•
Eli Lilly: Berenberg raises target price to $1,570 from $1,400
LLY•
Kinder Morgan target price raised to $37 from $36
KMI•
Kosmos Energy extends $1.2 billion reserve-based lending facility to April 2033
KOS•
Stryker Corporation: Raymond James cuts target price to $323 from $330
SYK•